MedPath

CureVac SE

CureVac SE logo
🇩🇪Germany
Ownership
Public, Subsidiary
Established
2000-01-01
Employees
251
Market Cap
$735.7M
Website
http://www.curevac.com
curevac.com
·

CureVac Partner GSK Announces Positive Phase 2 Data from Seasonal Influenza mRNA

CureVac N.V.’s press release includes forward-looking statements about future events and results, such as potential vaccine efficacy, strategies, financing plans, and market growth. These statements are not guarantees and are subject to risks, including economic conditions, regulatory approval, competition, and the COVID-19 pandemic. The company does not update forward-looking statements and advises readers to consult SEC filings for further information.
© Copyright 2025. All Rights Reserved by MedPath